Healthcare

Image

Australia Anemia in Pregnancy Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Feb 2023
  • Country Level
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Australia Anemia in Pregnancy Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 160.71 Billion
Diagram Market Size (Forecast Year) USD 315.55 Billion
Diagram CAGR %

Australia Anemia in Pregnancy Market, By Cause (Folic Acid Deficiency, Iron Deficiency, Vitamin B12 Deficiency, and Others), Treatment (Iron Products, Folic Acid Supplementation, and Others), Route of Administration (Oral, Intravenous, and Intramuscular), Prescribing Weeks (

Australia Anemia in Pregnancy Market Analysis and Size

Anemia is one of the most widespread blood disorders in recent times. The growing R&D in developing new treatment options and advancements in diagnostic procedures is anticipated to increase the growth of anemia in the pregnancy market. Deficiency of iron in women is the most common cause of anemia during pregnancy. The incidence of anemia in pregnancy was higher than previously estimated in Australia, being more common in the tertiary public hospital setting and with advancing gestation.

Data Bridge Market Research analyses a growth rate in the anemia in the pregnancy market in the forecast period 2023-2030. The expected CAGR of anemia in the pregnancy market tends to be around 8.8% in the mentioned forecast period. The market was valued at USD 160.71 million in 2022 and would grow to USD 315.55 million by 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Australia Anemia in Pregnancy Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2030

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Cause (Folic Acid Deficiency, Iron Deficiency, Vitamin B12 Deficiency, and Others), Treatment (Iron Products, Folic Acid Supplementation, and Others), Route of Administration (Oral, Intravenous, and Intramuscular), Prescribing Weeks (< 13 Weeks, 13-27 Weeks and ≥28 Weeks), End User (Hospitals, Specialty Clinics, Home Healthcare, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others)

Market Players Covered

Viatris Inc.(U.S.), Aspen Pharmacare Australia Pty Ltd (Australia), PharmaCare Laboratories Australia (Australia), AFT Pharmaceuticals (New Zealand), Bayer AG (Germany), A Nelson & Co Ltd (U.K.), BLACKMORES (Australia) and Care Pharma (India)

Market Opportunities

  • Growing Prevalence of Chronic Kidney Disease
  • Increasing Agreements and Collaborations

Market Definition

Anemia is a condition when the body does not have produce enough red blood cells to carry oxygen to tissues. Anemia during pregnancy is common as the body requires enough blood to support the baby's growth. The normal nutrients taken by a woman are not enough when conceiving, as there is a high requirement for iron and folate during the second and third trimesters of pregnancy. Mild anemia is usually witnessed in every pregnant woman, but the severity rises because of low iron or vitamin levels in the body and other reasons.  

Australia Anemia in Pregnancy Market Dynamics

Drivers

  • Increasing Incidence of Anemia

Anaemia is a prevalent condition witnessed in Australia and around the world, affecting more than 1.5 billion people globally. It is particularly widespread in certain populations: in Australia, about 12 percent of women, 8 percent of pre-school-aged children, and 20 percent of people over 85 years are anemic. The burden of anemia among the Australian population is higher than in the general population, despite high anemia prevalence. According to the National Heart, Lung, and Blood Institute, an expected 3 million individuals suffer from anemia in Australia. The growing incidence of target diseases, such as rheumatoid arthritis, kidney conditions, autoimmune diseases, liver disorders, thyroid diseases, cancer, and inflammatory bowel diseases, is a primary factor helping the market's growth. Thus, this boosts the growth of the market.

Opportunities

  • Growing Prevalence of Chronic Kidney Disease

According to the National Kidney Foundation, Inc. statistics, the two main causes of chronic kidney disease (CKD) are diab​​​​​​​etes and hypertension. More than 1 in 7, around 15% of Australian adults, are projected to have CKD. In 2017-18, around 1.0% of Australians had kidney disease. The incidence of kidney disease has remained relatively stable since 2011-12. It is anticipated that the prevalence of chronic kidney cases will rise across highly economic countries, such as the U.S., which infers an increase in the aged population over the upcoming years. 

  • Increasing Agreements and Collaborations  

Several contracts and agreements are initiated by the market players globally who are also increasing the anemia in the pregnancy market. For instance, Viatris Inc. announced in 2021 that the company participated in the 42nd Annual Global Healthcare Conference of Goldman Sachs, which was organized on June 10, 2021. The company's chief executive officer and the president will answer any queries associated with the company by globally attended customers. This is anticipated to increase the company's recognition. This creates more opportunities in the market.

Restraints/Challenges

  • Adverse Effects of Iron Supplements

Few serious effects are related to the intake of iron drugs. Common effects include digestive problems such as nausea, stomach aches, loss of appetite, constipation, and vomiting. The high dose of these drugs may also cause tiredness or weakness, shallow or rapid breathing, bluish skin, fatigue, convulsions, pale skin, or fingernails. Thus, this impedes market growth.

This anemia in pregnancy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the anemia in pregnancy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.  

Australia Anemia in Pregnancy Market Scope

The anemia in pregnancy market is segmented on the basis of cause, treatment, route of administration, prescribing weeks, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Cause

  • Folic Acid Deficiency
  • Iron Deficiency
  • Vitamin B12 Deficiency
  • Others

Treatment

  • Iron Products
  • Folic Acid Supplementation
  • Others

Route of Administration

  • Oral
  • Intravenous
  • Intramuscular

Weeks

  • < 13 Weeks
  • 13-27 Weeks
  • ≥28 Weeks

End-Users

  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Competitive Landscape and Australia Anemia in Pregnancy Market Share Analysis

The anemia in pregnancy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Australia presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to anemia in pregnancy market.

Key players operating in the anemia in pregnancy market include:

  • Viatris Inc. (U.S.)
  • Aspen Pharmacare Australia Pty Ltd (Australia)
  • PharmaCare Laboratories Australia (Australia)
  • AFT Pharmaceuticals (New Zealand)
  • Bayer AG (Germany)
  • A Nelson & Co Ltd (U.K.)
  • BLACKMORES (Australia)
  • Care Pharma (India)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The anemia in pregnancy market was USD 160.71 million in 2022.
The anemia in pregnancy market is projected to grow at a CAGR of 8.8% during the forecast period of 2022-2030.
The Australia Anemia in Pregnancy Market report is segmented by cause, treatment, route of administration, prescribing weeks, end user and distribution channel.
The top players are Viatris Inc.(U.S.), Aspen Pharmacare Australia Pty Ltd (Australia), PharmaCare Laboratories Australia (Australia), AFT Pharmaceuticals (New Zealand), Bayer AG (Germany), A Nelson & Co Ltd (U.K.), BLACKMORES (Australia) and Care Pharma (India)
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials